The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127632091 12763209 1 I 20160704 20160915 20160920 20160920 EXP US-MEDA-2016090054 MEDA 0.00 E F Y 109.00000 KG 20160920 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127632091 12763209 1 PS AZELASTINE HYDROCHLORIDE. AZELASTINE HYDROCHLORIDE 1 Nasal 20114 SOLUTION
127632091 12763209 2 SS EYLEA AFLIBERCEPT 1 Intraocular RIGHT EYE, ONCE MONTHLY FOR 3 INJECTIONS THEN EVERY 2 MONTHS 0 2 MG INJECTION
127632091 12763209 3 SS EYLEA AFLIBERCEPT 1 Intraocular RIGHT EYE, ONCE MONTHLY FOR 3 INJECTIONS THEN EVERY 2 MONTHS 0 2 MG INJECTION
127632091 12763209 4 SS EYLEA AFLIBERCEPT 1 Intraocular RIGHT EYE, ONCE MONTHLY FOR 3 INJECTIONS THEN EVERY 2 MONTHS 0 2 MG INJECTION
127632091 12763209 5 SS GABAPENTIN. GABAPENTIN 1 QD 0
127632091 12763209 6 SS GABAPENTIN. GABAPENTIN 1 0
127632091 12763209 7 SS FLONASE FLUTICASONE PROPIONATE 1 Nasal 0
127632091 12763209 8 SS MONTELUKAST SODIUM. MONTELUKAST SODIUM 1 0 10 MG QD
127632091 12763209 9 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 0 2 DF BID
127632091 12763209 10 SS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 0
127632091 12763209 11 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 0 10 MG QD
127632091 12763209 12 SS ALBUTEROL. ALBUTEROL 1 0 180 UG
127632091 12763209 13 C LOSARTAN AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM 1 0
127632091 12763209 14 C ZETIA EZETIMIBE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127632091 12763209 1 Asthma
127632091 12763209 2 Neovascular age-related macular degeneration
127632091 12763209 3 Neovascular age-related macular degeneration
127632091 12763209 4 Neovascular age-related macular degeneration
127632091 12763209 5 Spinal column stenosis
127632091 12763209 6 Spinal column stenosis
127632091 12763209 7 Asthma
127632091 12763209 8 Asthma
127632091 12763209 9 Asthma
127632091 12763209 10 Asthma
127632091 12763209 11 Asthma
127632091 12763209 12 Asthma

Outcome of event

Event ID CASEID OUTC COD
127632091 12763209 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127632091 12763209 Asthma
127632091 12763209 Drug ineffective for unapproved indication
127632091 12763209 Eosinophil count increased
127632091 12763209 Off label use
127632091 12763209 Pulmonary function test decreased
127632091 12763209 Transient ischaemic attack

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127632091 12763209 2 20160524 20160524 0
127632091 12763209 3 20160621 20160621 0
127632091 12763209 4 20160719 20160719 0
127632091 12763209 5 201601 201602 0
127632091 12763209 6 20160703 201607 0